ArticleEuropean urology oncology2024

Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer.

Assaf Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.